Step Pharma selected by a panel of 15 European investors as a winner in the MATWIN OUI event

Paris, France, 23 October 2020 – Step Pharma SAS have been ranked 1st among eleven cancer research companies by the MATWIN second OUI (Oncology Upward Investment) investor event, designed to help secure financial backing for promising innovations. More info (Matwin press release).